ArticleEuropean journal of nuclear medicine and molecular imaging2026
NHOC/NHOP as novel biomarkers for predicting lymph node metastasis in NSCLC using PET/CT radiomics and machine learning: a two-center retrospective study.
Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Reproducibility and Potential Prognostic Value of Spatial Metabolic PET Metrics in Oral Tongue Squamous Cell Carcinoma.Cancers · 2026Article
- PreoperativeTranslational lung cancer research · 2026Article
- Development of a computed tomography radiomics and CD38 integrated model: predicting immunotherapy response and investigating biological implications in non-small cell lung cancer.Journal of thoracic disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
purposeNHOC and NHOP, defined as the normalized distances from peak uptake to tumour centroid and perimeter, are novel PET/CT metrics of tumour aggressiveness. This two-centre study assessed the baseline NHOC/NHOP for predicting lymph node metastasis (LNM) in non-small cell lung cancer (NSCLC), then developed and validated an interpretable machine learning model combining clinical data, NHOC/NHOP and PET radiomics for LNM and occult nodal metastasis (ONM) prediction.
methods342 patients from two centres underwent 18F-FDG PET/CT scans, and data were divided into training (n = 188), internal (n = 63), and external (n = 91) sets. NHOC/NHOP and 284 radiomics features were initially extracted using LIFEx software. These features were normalized using Z-score and harmonized via ComBat. To avoid single algorithmic bias, eight machine-learning models were trained on the optimal radiomics features. The best-performing algorithm was employed to develop four predictive models including clinical, NHOC/NHOP, radiomics, and their combination. Shapley Additive Explanations (SHAP) values were used to interpret model contributions.
resultsKey independent predictors were PD-L1 value, lesion size and the novel biomarker NHOC, establishing the clinical model (PD-L1 and size) and the NHOC model. The multi-layer perceptron classifier (MLP) model achieved the highest Area Under the Curve (AUC) (0.82, 95% CI: 0.69-0.92). For LNM prediction, the combined model demonstrated superior performance across training (AUC 0.852), internal test (AUC 0.822), and external test (AUC 0.885) sets. It significantly outperformed clinical and NHOC models (p < 0.05). For ONM prediction, the combined model achieved the AUC (0.85) on the full datasets. SHAP analysis highlighted key features like GLCM_InverseVariance-PET and NGTDM_Strength-CT. A nomogram and online calculator were developed, with decision-curve analysis confirming superior net clinical benefit.
conclusionThis study established an accurate, interpretable machine learning model for preoperative prediction of LNM and ONM in NSCLC. NHOC emerged as a novel independent predictor with respect to classical PET parameters.
Indexed as
Identifiers
41137928What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.